Association of low-density lipoprotein receptor polymorphisms and outcome of hepatitis C infection

[1]  Y. Uematsu,et al.  The small extracellular loop of CD81 is necessary for optimal surface expression of the large loop, a putative HCV receptor. , 2001, Virus research.

[2]  A. Hill.  Immunogenetics and genomics , 2001, The Lancet.

[3]  M. Thursz.  MHC and the viral hepatitides. , 2001, QJM : monthly journal of the Association of Physicians.

[4]  P. Donnelly,et al.  A new statistical method for haplotype reconstruction from population data. , 2001, American journal of human genetics.

[5]  R. Zinkernagel,et al.  Hypercholesterolemia Exacerbates Virus-Induced Immunopathologic Liver Disease Via Suppression of Antiviral Cytotoxic T Cell Responses1 , 2001, The Journal of Immunology.

[6]  N. Enomoto,et al.  CD81 nucleotide mutation in hepatocellular carcinoma and lack of CD81 polymorphism in patients at stages of hepatitis C virus infection , 2001, Journal of medical virology.

[7]  B. Clarke,et al.  Receptors for Hepatitis C Virus , 2000, Journal of Virology.

[8]  K. Meyer,et al.  Functional features of hepatitis C virus glycoproteins for pseudotype virus entry into mammalian cells. , 2000, Virology.

[9]  M. Hirata,et al.  Seven DNA polymorphisms at the candidate genes of atherosclerosis in Brazilian women with angiographically documented coronary artery disease. , 2000, Clinica chimica acta; international journal of clinical chemistry.

[10]  N. Kinukawa,et al.  Beta-lipoproteins influence the serum level of hepatitis C virus. , 2000, Medical science monitor : international medical journal of experimental and clinical research.

[11]  M. Houghton,et al.  Structure-Function Analysis of Hepatitis C Virus Envelope-CD81 Binding , 2000, Journal of virology.

[12]  A. Nicosia,et al.  Identification of Amino Acid Residues in CD81 Critical for Interaction with Hepatitis C Virus Envelope Glycoprotein E2 , 2000, Journal of Virology.

[13]  D. Purdie,et al.  Host genetic factors influence disease progression in chronic hepatitis C , 2000, Hepatology.

[14]  M. Carrington,et al.  Chronic viral hepatitis and the human genome , 2000, Hepatology.

[15]  P. Yamwong,et al.  Effect of Ava II and NcoI polymorphisms at the low density lipoprotein receptor gene on plasma lipid levels in a group of Thai subjects. , 2000, Journal of the Medical Association of Thailand = Chotmaihet thangphaet.

[16]  Gonçalo R. Abecasis,et al.  GOLD-Graphical Overview of Linkage Disequilibrium , 2000, Bioinform..

[17]  Mark Thursz,et al.  Influence of MHC class II genotype on outcome of infection with hepatitis C virus , 1999, The Lancet.

[18]  V. Agnello,et al.  Hepatitis C virus and other flaviviridae viruses enter cells via low density lipoprotein receptor. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[19]  D. Purdie,et al.  Interleukin‐10 promoter polymorphism predicts initial response of chronic hepatitis C to interferon alfa , 1999, Hepatology.

[20]  G. Minuk,et al.  The influence of host factors on the natural history of chronic hepatitis C viral infections , 1999, Journal of viral hepatitis.

[21]  R. Thomssen,et al.  Low density lipoprotein receptor as a candidate receptor for hepatitis C virus , 1999, Journal of medical virology.

[22]  M. Houghton,et al.  Binding of hepatitis C virus to CD81. , 1998, Science.

[23]  M. Emi,et al.  Molecular genetic diagnosis of a family with hypercholesterolemia by a mismatched PCR-RFLP method for genotyping single base substitution of the LDL receptor gene. , 1998, Japanese heart journal.

[24]  K. Mehta,et al.  Differential Roles of Extracellular Signal-regulated Kinase-1/2 and p38MAPK in Interleukin-1β- and Tumor Necrosis Factor-α-induced Low Density Lipoprotein Receptor Expression in HepG2 Cells* , 1998, The Journal of Biological Chemistry.

[25]  J. Grove,et al.  Heterozygosity for hereditary hemochromatosis is associated with more fibrosis in chronic hepatitis C , 1998, Hepatology.

[26]  G. Gerken,et al.  Tumor necrosis factor alpha promoter polymorphism at position ‐238 is associated with chronic active hepatitis C infection , 1998, Journal of medical virology.

[27]  J. Pawlotsky,et al.  Hemochromatosis Cys282Tyr mutation and liver iron overload in patients with chronic active hepatitis C , 1998, Hepatology.

[28]  K. Feingold,et al.  Lipoproteins: Are they important components of host defense? , 1997, Hepatology.

[29]  V. Agnello,et al.  Localization of hepatitis C virus in cutaneous vasculitic lesions in patients with type II cryoglobulinemia. , 1997, Arthritis and rheumatism.

[30]  W. Stremmel,et al.  Establishment of persistent hepatitis C virus infection and replication in vitro. , 1997, The Journal of general virology.

[31]  J. Kuiper,et al.  Human recombinant apolipoprotein E redirects lipopolysaccharide from Kupffer cells to liver parenchymal cells in rats In vivo. , 1997, The Journal of clinical investigation.

[32]  S. Levy,et al.  The tetraspanin superfamily: molecular facilitators , 1997, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[33]  P. Bedossa,et al.  Natural history of liver fibrosis progression in patients with chronic hepatitis C , 1997, The Lancet.

[34]  F. Chaves,et al.  Seven DNA polymorphisms in the LDL receptor gene: application to the study of familial hypercholesterolemia in Spain , 1996, Clinical genetics.

[35]  M. Netea,et al.  Low-density lipoprotein receptor-deficient mice are protected against lethal endotoxemia and severe gram-negative infections. , 1996, The Journal of clinical investigation.

[36]  J. Taylor,et al.  Macrophage-specific expression of human apolipoprotein E reduces atherosclerosis in hypercholesterolemic apolipoprotein E-null mice. , 1995, The Journal of clinical investigation.

[37]  F. Barany,et al.  Detection of steroid 21-hydroxylase alleles using gene-specific PCR and a multiplexed ligation detection reaction. , 1995, Genomics.

[38]  K. Ishak,et al.  Histological grading and staging of chronic hepatitis. , 1995 .

[39]  L. Blatt,et al.  Type 1 interferon as an antiinflammatory agent: inhibition of lipopolysaccharide-induced interleukin-1 beta and induction of interleukin-1 receptor antagonist. , 1995, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[40]  B. Morris,et al.  Association of HincII RFLP of low density lipoprotein receptor gene with obesity in essential hypertensives , 1995, Clinical genetics.

[41]  V. Gudnason,et al.  Effect of the StuI polymorphism in the LDL receptor gene (Ala 370 to Thr) on lipid levels in healthy individuals , 1995, Clinical genetics.

[42]  D. Novick,et al.  Isolation and Characterization of a Soluble Form of the LDL Receptor, an Interferon-Induced Antiviral Protein , 1994, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[43]  E. Kuechler,et al.  Members of the low density lipoprotein receptor family mediate cell entry of a minor-group common cold virus. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[44]  H. Varmus,et al.  A receptor for subgroup A Rous sarcoma virus is related to the low density lipoprotein receptor , 1993, Cell.

[45]  H. Tilg,et al.  Induction of circulating IL-1 receptor antagonist by IFN treatment. , 1993, Journal of immunology.

[46]  A. Miserez,et al.  Polymorphic haplotypes and recombination rates at the LDL receptor gene locus in subjects with and without familial hypercholesterolemia who are from different populations. , 1993, American journal of human genetics.

[47]  Z. Píša,et al.  Normal genetic variation at the low density lipoprotein receptor (LDLR) locus influences cholesterol levels in children , 1993, Clinical genetics.

[48]  S. Bertolini,et al.  Use of three DNA polymorphisms of the LDL receptor gene in the diagnosis of familial hypercholesterolemia , 1990, Human Genetics.

[49]  P. Brink,et al.  A DNA polymorphism in the human low-density lipoprotein receptor gene. , 1986, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

[50]  P. Marcellin,et al.  Hepatitis C: the clinical spectrum of the disease. , 1999, Journal of hepatology.

[51]  D. Strickland,et al.  The mammalian low-density lipoprotein receptor family. , 1999, Annual review of nutrition.

[52]  C. Datz,et al.  The relation of iron status and hemochromatosis gene mutations in patients with chronic hepatitis C. , 1999, Gastroenterology.

[53]  L. Vladimirova,et al.  LDL-receptor gene polymorphism in patients with early-onset coronary artery disease. , 1998, Folia medica.

[54]  C. Dinarello,et al.  Interleukin-1, interleukin-1 receptors and interleukin-1 receptor antagonist. , 1998, International reviews of immunology.

[55]  H. Hobbs,et al.  Molecular genetics of the LDL receptor gene in familial hypercholesterolemia , 1992, Human mutation.

[56]  T. Farag,et al.  Familial hypercholesterolemia. , 1988, Journal of the Royal Society of Medicine.